• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRIâ„¢ Website
      • ISPRI Downselectâ„¢
      • ISPRI Quantifyâ„¢
      • ISPRI Analyzeâ„¢
      • ISPRI Evaluateâ„¢
      • ISPRI-HCPâ„¢
      • ISPRI Designâ„¢
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAXâ„¢
      • EpiCCâ„¢
      • Ancer®
      • PreVAXâ„¢
    • Lab Services
      • All In Vitro Assays
      • Generic Peptide PANDA® Assays
    • Consulting Services
      • Trusted Expert Advice (TEA)
      • IRA / ISI Regulatory Writing Support
    • Why Immunogenicity Risk Assessment?
    • Why EpiVax?
  • About Us
    • Company History
    • Leadership
    • Careers
  • Press
    • News
    • Events
    • Publications
    • Blog
  • Contact Us
Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences

Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences

by Adam | Oct 22, 2016

Vaccine 1995, Vol. 13, No. 6, pp. 581-591.
Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-09 Conventional Influenza Vaccine

Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-09 Conventional Influenza Vaccine

by Adam | Oct 22, 2016

Vaccine. 2009 Sep 25;27(42):5740-7. PMID: 19660593.
Prediction of well-conserved HIV-1 ligands using a Matrix-based Algorithm, EpiMatrix

Prediction of well-conserved HIV-1 ligands using a Matrix-based Algorithm, EpiMatrix

by Adam | Oct 22, 2016

Vaccine, 1998, Vol. 16, No. 19, pp. 1880-1884.
From genome to vaccine: In silico predictions, ex vivo verification

From genome to vaccine: In silico predictions, ex vivo verification

by Adam | Oct 22, 2016

Vaccine 2001 Aug 14; 19(31):4385-95.
Mapping Cross-Clade HIV-1 Vaccine Epitopes Using a Bioinformatics Approach

Mapping Cross-Clade HIV-1 Vaccine Epitopes Using a Bioinformatics Approach

by Adam | Oct 22, 2016

Vaccine 21 (2003) 4486–4504. https://www.sciencedirect.com/science/journal/0264410X.
« Older Entries

Recent Posts

  • EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services    
  • Replacing Animal Models with Human-Relevant New Approach Methodologies (NAMs) for Immunogenicity in Clinic
  • EpiVax Enters its Next Chapter with SV Health Investors
  • Immunogenicity Risk Assessment Outputs to Drive a Streamlined, Risk-Based Preclinical and Clinical Strategy
  • Immunogenicity Risk Assessment Outputs to Drive a Streamlined, Risk-Based Preclinical and Clinical Strategy

Recent Comments

No comments to show.

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

News

Events

Publications

Contact Us

This website uses cookies and similar technologies to collect information about your website experience for advertising, analytics, and other purposes as described in our Privacy Policy.